New York State Common Retirement Fund Surface Oncology, Inc. Transaction History

New York State Common Retirement Fund

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$1.42 - $3.15 $20,448 - $45,360	-14,400 Reduced 98.03%	290 $0
Q4 2021 Feb 02, 2022	SELL	$4.73 - $7.9 $297 - $497	-63 Reduced 0.43%	14,690 $70,000
Q3 2021 Nov 02, 2021	SELL	$5.16 - $7.98 $70,934 - $109,701	-13,747 Reduced 48.24%	14,753 $112,000
Q2 2021 Aug 02, 2021	BUY	$6.45 - $9.09 $183,825 - $259,065	28,500 New	28,500 $213,000
Q2 2019 Aug 09, 2019	SELL	$2.75 - $4.89 $22,000 - $39,120	-8,000 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$12.83 - $17.41 $102,640 - $139,280	8,000 New	8,000 $130,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.